SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Feb-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 23-Feb-24 | Grant | 1,250 | -- | -- | 32% 3.96K to 5.21K | |
27-Feb-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 23-Feb-24 | Payment of Exercise | 567 | $29.06 | $16,477.00 | (11%) 5.21K to 4.64K | |
26-Feb-24 5:02 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-24 | Grant | 750 | -- | -- | 21% 3.51K to 4.26K | |
26-Feb-24 5:02 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-24 | Payment of Exercise | 303 | $27.94 | $8,465.82 | (7%) 4.26K to 3.96K | |
26-Dec-23 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Dec-23 | Payment of Exercise | 204 | $27.66 | $5,642.64 | (6%) 3.45K to 3.24K | |
26-Dec-23 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Dec-23 | Option Exercise | 600 | -- | -- | 21% 2.85K to 3.45K | |
24-Feb-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-23 | Grant | 750 | -- | -- | 43% 1.75K to 2.5K | |
21-Feb-23 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 16-Feb-23 | Option Exercise | 1,500 | -- | -- | 100% 0 to 1.5K |